On biopsy, this was an infiltratingductalcarcinoma. 活检证实为乳腺浸润性导管癌. 互联网 Treatment ofductalcarcinoma in situ . [ comment ] . 治疗 乳腺 导管内癌. 互联网 The irregular mass lesion seen here is an infiltratingductalcarcinoma of breast. ...
63 、Here is a side by side comparison of the gross characteristics of a classic infiltratingductalcarcinoma on the left and a benign fibroadenoma on the right.───左边典型的浸润性导管癌与右边良性纤维腺瘤的肉眼特征的近距离比较。 64 、Also, it acts as a biospecimen repository in which patient...
拉法基豪瑞(LafargeHolcim)-Ductal-穿孔遮阳板 产品介绍Ductal®是拉法基豪瑞(LafargeHolcim)集团旗下研发的一种创新型高科技建筑材料(又称超高性能混凝土-UHPC),具备卓越的抗压强度、延展性…… 包含 拉法基豪瑞(LafargeHolcim)-Ductal-复合板 产品介绍Ductal®是拉法基豪瑞(LafargeHolcim)集团旗下研发的一种创新型高科技...
Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations. Am J Pathol. 2002;160:1361–9. Article CAS PubMed PubMed Central Google Scholar Springer S, Wang Y, Dal Molin M, Masica DL, Jiao Y, ...
Pancreatic ductal adenocarcinoma is believed to arise from precursor lesions termed pancreatic intraepithelial neoplasia (PanIN). Mouse models have demonstrated that targeted expression of activated K-ras to mature acinar cells in the pancreas induces the spontaneous development of PanIN lesions; implying ac...
用Ductal®建筑结构时的混凝土用量是传统混凝土结构用量的1/2到1/3,而且可以取消钢筋。这两项可以使建筑工程总造价大幅度降低:基础尺寸减小、施工组织和供应更方便、工期缩短、日后维修减少。总之,尽管原材料价格高于传统混凝土,但由于提高了技术含量,Ductal提高了从供应商、建筑商到最终客户这一产业链经济效益的附加...
利用Ductal开发封闭放射性核废料的容器
北京UHPC | Ductal UHPC案例鉴赏——盖尼特拉火车站 盖尼特拉火车站位于摩洛哥，是丹吉尔至盖尼特拉高速铁路的战略要地之一。其装饰采用UHPC材料，外观宏伟大气，成为该国经济发展的新象征。该火车站是摩洛哥高铁项目的第一个连接部分,旨在到2030年，为国家提供1500千米的高速铁路，并连接城市和商业区域与两个经济中心。
ductal carcinoma in situ释义 常用 牛津词典 释义 [医]原位管癌;双语例句 全部 1. Treatment of ductal carcinoma in situ . [ comment ] . 治疗 乳腺 导管内癌. 来自互联网 2. Objective To study radiologic ( molybdenum target X - ray ) findings of ductal carcinoma in situ ( DCIS ) of breast....
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer that is most frequently detected at advanced stages, limiting treatment options to systemic chemotherapy with modest clinical responses. Here, we review recent advances in targeted therapy and immunotherapy for treating subtypes of PDAC with ...